Comparison of Long-Term Outcomes in Real-World Patients Between Resolute Zotarilumus-Eluting and Paclitaxel-Eluting Stents in Small Vessel

Conclusion:
The rates of major adverse cardiac events and cardiac death were similar in the R-ZES-treated group compared with the PES-treated group.

Source: Angiology - April 11, 2016 Category: Cardiology Authors: Kilickesmez, K. O., Kocas, B., Yildiz, A., Coskun, U., Ersanli, M., Arat, A., Gürmen, T. Tags: Stenting Source Type: research